George Elston | executive |
Jay Duker | executive |
Tessa Romero | analyst |
Ramiro Ribeiro | executive |
Tyler Van Buren | analyst |
Yatin Suneja | analyst |
Jennifer Kim | analyst |
Graig Suvannavejh | analyst |
Colleen Hanley | analyst |
Yale Jen | analyst |
Yi Chen | analyst |
Good morning. My name is Kevin, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the EyePoint Pharmaceuticals Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments conference call. There will be a question and answer session to follow at the completion of the prepared remarks. Please be advised this call is being recorded at the company's request.